Transforming Growth Factor-β Gene Polymorphisms in Sarcoidosis Patients With and Without Fibrosis
Chest, ISSN: 0012-3692, Vol: 129, Issue: 6, Page: 1584-1591
2006
- 92Citations
- 29Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations92
- Citation Indexes92
- 92
- CrossRef60
- Captures29
- Readers29
- 29
Article Description
Pulmonary fibrosis develops in approximately 25% of patients with chronic sarcoidosis. Transforming growth factor (TGF)-β1 plays a central role in fibrosis, and accruing reports address the implication of TGF-β2 and TGF-β3 in this process. We determined whether single-nucleotide polymorphisms (SNPs) in the TGF-β1, TGF-β2, and TGF-β3 genes might contribute to pulmonary fibrosis in sarcoidosis patients. A hospital in the Netherlands. Five SNPs per TGF-β gene were investigated. Patients with either acute/self-remitting sarcoidosis (n = 50) and Löfgren syndrome (n = 46) or chronic disease with fibrosis (n = 24) and without fibrosis (n = 34) were assessed over a 4-year follow-up period. The control subjects included 315 individuals. Polymorphism frequencies were not discordant between the patients and control subjects. The TGF-β3 4875 A allele was significantly higher in fibrotic patients (carrier frequency, 0.29) than in patients with acute/self-remitting (0.06) and chronic (0.03) sarcoidosis combined (corrected p = 0.01; odds ratio [OR], 7.9). The TGF-β3 17369 C allele carrier frequency was significantly higher in fibrotic patients (0.29) compared to acute/self-remitting (0.08) and chronic (0.06) patients combined (corrected p = 0.05; OR, 5.1). Although not significant after correction, the TGF-β3 15101 G allele carrier frequency was lower in fibrotic patients (0.79) compared to acute/self-remitting (0.94) and chronic (1.00) patients combined (p = 0.02; corrected p = 0.1; OR, 0.15). The TGF-β2 59941 G allele was more abundant in fibrotic patients (carrier frequency, 0.62) compared to patients with acute/self-remitting (0.41) and chronic sarcoidosis combined (0.28) [p = 0.04; corrected p = 0.2; OR, 2.9]. TGF-β1 gene polymorphisms were not associated with fibrosis. This study is the first to suggest the implication of genetic variation of TGF-β3 in the predilection for pulmonary fibrosis developing in sarcoidosis patients.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0012369215507642; http://dx.doi.org/10.1378/chest.129.6.1584; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33745178891&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/16778279; https://linkinghub.elsevier.com/retrieve/pii/S0012369215507642; https://dx.doi.org/10.1378/chest.129.6.1584
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know